FIELD: medicine.
SUBSTANCE: invention describes a method for prediction of a risk of developing benign mammary dysplasia in females with genital endometriosis involving DNA recovery from peripheral venous blood, determination of gene polymorphism of type 1 tumor necrosis factor a receptor (+36 A/G TNFR1). Detecting the genotypes +36 AA TNFR1 and +36 AG TNFR1 enables predicting the high risk of developing benign mammary dysplasia in genital endometriosis.
EFFECT: use of the method enables predicting the risk of the onset of benign mammary hyperplasia in the patients with genital endometriosis and thereby determining the further approach to the patients with genital endometriosis.
1 tbl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF ENDOMETRIUM HYPERPLASIA IN WOMEN WITH GENITAL ENDOMETRIOSIS | 2011 |
|
RU2468367C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING BREAST CANCER IN WOMEN WITH OBESITY BASED ON DATA ON POLYMORPHISM OF GENES JMJD1C, PPP1R21 AND PRMT6 | 2024 |
|
RU2830467C1 |
| METHOD FOR PREDICTION OF CHARACTER OF UTERINE INVOLVEMENT IN MYOMATOUS NODES | 2010 |
|
RU2453850C2 |
| METHOD FOR PREDICTION OF INCREASED RISK OF DEVELOPING BREAST CANCER OF 3-4 STAGES OF DISEASE IN WOMEN | 2024 |
|
RU2830466C1 |
| METHOD FOR PREDICTING RISK OF GRADE 3 MALIGNANCY OF TUMOR CELLS IN BREAST CANCER | 2024 |
|
RU2830352C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING LUMINAL SUBTYPE OF BREAST CANCER IN WOMEN | 2024 |
|
RU2828523C1 |
| METHOD FOR PREDICTION OF RISK OF HYPERPLASTIC PROCESSES OF ENDOMETRIUM | 2014 |
|
RU2557977C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING BREAST CANCER IN WOMEN WITHOUT OBESITY BY RESULTS OF GENETIC TESTING | 2024 |
|
RU2828525C1 |
| METHOD FOR PREDICTING RISK OF ENDOMETRIAL HYPERPLASTIC PROCESSES BASED ON GENETIC DATA | 2017 |
|
RU2650988C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF MYOMATOUS NODES OF LARGE SIZES IN PATIENTS WITH MYOMA | 2016 |
|
RU2616246C1 |
